Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Tax Provisions (2016 - 2025)

Angiodynamics (ANGO) has disclosed Tax Provisions for 16 consecutive years, with -$5000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 95.45% year-over-year to -$5000.0, compared with a TTM value of -$2000.0 through Nov 2025, up 99.98%, and an annual FY2025 reading of -$39000.0, up 99.46% over the prior year.
  • Tax Provisions was -$5000.0 for Q4 2025 at Angiodynamics, down from $65000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $16.4 million in Q4 2023 and bottomed at -$12.0 million in Q1 2024.
  • Average Tax Provisions over 5 years is -$785950.0, with a median of -$483500.0 recorded in 2021.
  • The sharpest move saw Tax Provisions soared 3007.96% in 2023, then plummeted 6606.15% in 2024.
  • Year by year, Tax Provisions stood at -$512000.0 in 2021, then decreased by 10.35% to -$565000.0 in 2022, then skyrocketed by 3007.96% to $16.4 million in 2023, then plummeted by 100.67% to -$110000.0 in 2024, then soared by 95.45% to -$5000.0 in 2025.
  • Business Quant data shows Tax Provisions for ANGO at -$5000.0 in Q4 2025, $65000.0 in Q3 2025, and -$60000.0 in Q2 2025.